original ) (raw )Discrepancies in apparent dopamine D2 receptor occupancy between 3 H-raclopride and 3 H-N-methylspiperone
Antony Gee
Journal of Neural Transmission, 1999
View PDFchevron_right
Dopamine D 3 receptor antagonists: The quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies
Cristian Salinas
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Quantification of D2Like Dopamine Receptors in the Human Brain with 18F-Desmethoxyfallypride
Ingo Vernaleken , Christoph Hiemke , Markus Piel
2000
View PDFchevron_right
Regulation of dopamine D1 receptors by chronic administration of structurally different D1 receptor antagonist: A quantitative autoradiographic study
Erkka Syvälahti
European Journal of Pharmacology, 1992
View PDFchevron_right
Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors
Robert McQuade
European Journal of Pharmacology, 2011
View PDFchevron_right
In Vivo Measurement of Receptor Density and Affinity: Comparison of the Routine Sequential Method With a Nonsequential Method in Studies of Dopamine D2 Receptors With [11C]Raclopride
Thomas Ruth
Journal of Cerebral Blood Flow & Metabolism, 2003
View PDFchevron_right
High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors
Tomas de Paulis
Life Sciences, 1991
View PDFchevron_right
18F-MCL-524, an 18F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study
Cathrine Jonsson
Journal of Nuclear Medicine, 2014
View PDFchevron_right
In Vitro and In Vivo Evaluation of N -{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[ 11 C]methoxybenzamide, a Positron Emission Tomography (PET) Radioligand for Dopamine D 4 Receptors, in Rodents
Svetlana Selivanova
Chemistry & Biodiversity, 2014
View PDFchevron_right
Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography
Tony Altar
The Journal of Neuroscience, 1987
View PDFchevron_right
In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride
Diana Martinez
Synapse, 2004
View PDFchevron_right
[125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors
J. Clanton
European Journal of Pharmacology, 1988
View PDFchevron_right
Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756
Béla Kiss
Brain Research Bulletin, 2005
View PDFchevron_right
In vivo evaluation of [123I]-8-[4-[2-(5-Iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1, 3, 8-triazaspiro [4.5] decan-4-one as a potential dopamine D2 receptor radioligand …
Timothy Gotsick
Nuclear medicine and …, 1998
View PDFchevron_right
Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15
Zsolt Némethy
View PDFchevron_right
Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, ( R, S)-5-hydroxy-2-( N-propyl- N-(5′- 18F-fluoropentyl)aminotetralin ( 18F-5-OH-FPPAT) in rodents and nonhuman primates
sankha chattopadhyay
Nuclear Medicine and Biology, 2004
View PDFchevron_right
Binding characteristics of high-affinity dopamine D2/D3 receptor agonists,11C-PPHT and11C-ZYY-339 in rodents and imaging in non-human primates by PET
Jogeshwar Mukherjee , Bradley Christian
Synapse, 2004
View PDFchevron_right
(S)-N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo-2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors
J. Clanton
Journal of Medicinal Chemistry, 1988
View PDFchevron_right
Human dopamine receptor subtypes?in vitro binding analysis using3H-SCH 23390 and3H-raclopride
Lars Farde
Journal of Neural Transmission, 1988
View PDFchevron_right
Dopamine D 2/3 receptor occupancy of apomorphine in the nonhuman primate brain-A comparative PET study with [ 11 C]raclopride and [ 11 C]MNPA
Lars Farde
Synapse, 2009
View PDFchevron_right
Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography
Lars Farde
Proceedings of the National Academy of Sciences, 1985
View PDFchevron_right
11C]Cyclopropyl-FLB 457: A PET radioligand for low densities of dopamine D 2 receptors
Jogeshwar Mukherjee , sankha chattopadhyay
Bioorganic & Medicinal Chemistry, 2008
View PDFchevron_right
Preliminary assessment of extrastriatal dopamine d-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride
Chin-tu Chen
Nuclear Medicine and Biology, 1999
View PDFchevron_right
[11C]A-69024: A potent and selective non-benzazepine radiotracer for in vivo studies of dopamine D1 receptors
Michael Kassiou
Nuclear Medicine and Biology, 1995
View PDFchevron_right
Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand
Porntip Supavilai
The Journal of neuroscience : the official journal of the Society for Neuroscience, 1987
View PDFchevron_right
N-0437:a selective D-2 dopamine receptor agonist in in vitro and in vivo models
Pieter Tepper
European Journal of Pharmacology, 1988
View PDFchevron_right
In vivo autoradiography of [3H]SCH 39166 in rat brain: selective displacement by D1/D5 antagonists
Robert McQuade
Journal of Chemical Neuroanatomy, 2000
View PDFchevron_right